ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,119, issued on July 28, was assigned to PTC Therapeutics MP Inc. (Warren, N.J.) and Virginia Commonwealth University (Richmond, Va.).

"Methods for treating covid-19 with sepiapterin" was invented by Gene Chatman Clark (Richmond, Va.), Eleonora Mezzaroma (Glen Allen, Va.), Christopher Rabender (Chesterfield, Va.), Ross B. Mikkelsen (Richmond, Va.), Vasily Yakovlev (Richmond, Va.) and Neil Smith (Cary, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention features methods of treating a SARS-CoV-2 infection in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable sa...